chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Starting the evening after the injection, the injection site became sore and red and took about a week to resolve and go away. This is the second dose of SHINGRIX and the same reaction occurred with dose 1. A previous VAERS report was submitted, I called the manufacturer to get direction on whether to administer the second dose and they said if patient was willing, I should go ahead and inject the 2nd dose when the time came. I did and she had another reaction, similar to the first.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Received the 1 shot of SHINGRIX on Friday afternoon, came in Monday afternoon saying that on Sunday she started noticing a rash on her trunk area, Monday she came in and was referred to md, who diagnosed rash as shingles.
Age: 42.0
Sex: F
Vaccine: PNC13
Symptoms: Arthralgia, Balance disorder, Decreased appetite, Disturbance in attention, Dizziness
Clinical narrative: 12/20/2018 approximately 1hour after receiving this vaccine PREVNAR 13 I felt off balance/dizzy; later in the evening I felt achey and tired and used 400 mg Ibuprofen every 6 hours. Right arm extremely tender hurt to move or touch, had zingy pain down right arm into right hand wrist hurt, forearm hurt. Loss of appetite. 12/21/2018 I had a difficult time concentrating at work due to being achey all over almost felt like having the flu, still using 400mg Ibuprofen every 6hours would not have made it without taking it. I felt completely wiped out extremely fatigued. Right arm still painful to touch, no appetite, joints hurt stiffness in right wrist. 12/22/2018 By Saturday I noticed about an 1 and a half from the actual injection site reddened somewhat raised rash several inches in diameter warm to touch still painful and swollen, still using 400 mg ibuprofen every 6hours. By Saturday evening felt a little better. 12/23/2018 Still using ibuprofen every 6-8hours for joint pain, right arm still reddened, not as much, not as tender. 12/24/2018 Feeling somewhat better using ibuprofen every 8-10 hours, right arm still reddened. 12/25/2018 arm still red ibuprofen every 12 hours. 12/26/2018 still red.
Age: 42.0
Sex: F
Vaccine: PNC13
Symptoms: Fatigue, Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: 12/20/2018 approximately 1hour after receiving this vaccine PREVNAR 13 I felt off balance/dizzy; later in the evening I felt achey and tired and used 400 mg Ibuprofen every 6 hours. Right arm extremely tender hurt to move or touch, had zingy pain down right arm into right hand wrist hurt, forearm hurt. Loss of appetite. 12/21/2018 I had a difficult time concentrating at work due to being achey all over almost felt like having the flu, still using 400mg Ibuprofen every 6hours would not have made it without taking it. I felt completely wiped out extremely fatigued. Right arm still painful to touch, no appetite, joints hurt stiffness in right wrist. 12/22/2018 By Saturday I noticed about an 1 and a half from the actual injection site reddened somewhat raised rash several inches in diameter warm to touch still painful and swollen, still using 400 mg ibuprofen every 6hours. By Saturday evening felt a little better. 12/23/2018 Still using ibuprofen every 6-8hours for joint pain, right arm still reddened, not as much, not as tender. 12/24/2018 Feeling somewhat better using ibuprofen every 8-10 hours, right arm still reddened. 12/25/2018 arm still red ibuprofen every 12 hours. 12/26/2018 still red.
Age: 42.0
Sex: F
Vaccine: PNC13
Symptoms: Joint stiffness, Pain, Pain in extremity, Tenderness
Clinical narrative: 12/20/2018 approximately 1hour after receiving this vaccine PREVNAR 13 I felt off balance/dizzy; later in the evening I felt achey and tired and used 400 mg Ibuprofen every 6 hours. Right arm extremely tender hurt to move or touch, had zingy pain down right arm into right hand wrist hurt, forearm hurt. Loss of appetite. 12/21/2018 I had a difficult time concentrating at work due to being achey all over almost felt like having the flu, still using 400mg Ibuprofen every 6hours would not have made it without taking it. I felt completely wiped out extremely fatigued. Right arm still painful to touch, no appetite, joints hurt stiffness in right wrist. 12/22/2018 By Saturday I noticed about an 1 and a half from the actual injection site reddened somewhat raised rash several inches in diameter warm to touch still painful and swollen, still using 400 mg ibuprofen every 6hours. By Saturday evening felt a little better. 12/23/2018 Still using ibuprofen every 6-8hours for joint pain, right arm still reddened, not as much, not as tender. 12/24/2018 Feeling somewhat better using ibuprofen every 8-10 hours, right arm still reddened. 12/25/2018 arm still red ibuprofen every 12 hours. 12/26/2018 still red.
Age: 71.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Back pain, Nausea, Pain
Clinical narrative: Patient reported experiencing shooting lower back pain that worsened with every step he took. He says he has never experienced pain like this before. He also became very nauseous. The back pain lasted about 30 minutes or so, but the nausea persisted for a few hours.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Fatigue, Myalgia, Pain
Clinical narrative: Thursday morning and afternoon from 9 am. - 5 p.m., fever (101.4 at its highest), intense shivering and chills, muscle pain, fatigue and weakness. I felt better by that evening but was sore and tired for a couple more days and arm was sore for four days.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Thursday morning and afternoon from 9 am. - 5 p.m., fever (101.4 at its highest), intense shivering and chills, muscle pain, fatigue and weakness. I felt better by that evening but was sore and tired for a couple more days and arm was sore for four days.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Chills, Cough, Fatigue, Headache, Myalgia
Clinical narrative: Fever/ chills, headache, muscle aches, fatigue, nonproductive cough.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Pyrexia
Clinical narrative: Fever/ chills, headache, muscle aches, fatigue, nonproductive cough.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Mobility decreased, Night sweats
Clinical narrative: EXTREME JOINT PAIN AND NIGHT SWEATS. COULD NOT GET OUT OF BED FOR A FEW HOURS.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Skin warm
Clinical narrative: Started with red round circle and has increased to larger area of arm being red and warm. Slight itch. Patient has no pain, is going to take allergy medication and anti-inflammatory to help with reaction. Knows to contact MD if anything changes.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain
Clinical narrative: Patient states that the day after she received her flu shot, she started experiencing pain at the injection site. Over the last two months the pain has gotten worse and it especially flares up when she makes certain movements like reaching for something or putting on a jacket.
Age: 61.0
Sex: F
Vaccine: TDAP
Symptoms: Asthenia, Chills, Dizziness, Headache, Hyperhidrosis
Clinical narrative: 12/21/18 - 12/25/18 I probably had a mild-moderate reaction to the Tdap Vaccine, which I received for work at a hospital on 12/21/18. Manufacturers Lot number: 3YM7S, date 11/9/20. I had slight soreness at the site, mild to moderate weakness and dizziness. I had chills and sweats for 2 days, with occasional twinges of headache, but no elevated temperature. It seemed like my left cheek was slightly swollen, but that may have been a trick of the lighting. I had no difficulty breathing. I suspected an allergic reaction because I've been developing more allergies in recent years, so I took a BENADRYL - the symptoms decreased gradually, and were gone in 2 more days.
Age: 61.0
Sex: F
Vaccine: TDAP
Symptoms: Hypersensitivity, Injection site pain
Clinical narrative: 12/21/18 - 12/25/18 I probably had a mild-moderate reaction to the Tdap Vaccine, which I received for work at a hospital on 12/21/18. Manufacturers Lot number: 3YM7S, date 11/9/20. I had slight soreness at the site, mild to moderate weakness and dizziness. I had chills and sweats for 2 days, with occasional twinges of headache, but no elevated temperature. It seemed like my left cheek was slightly swollen, but that may have been a trick of the lighting. I had no difficulty breathing. I suspected an allergic reaction because I've been developing more allergies in recent years, so I took a BENADRYL - the symptoms decreased gradually, and were gone in 2 more days.
Age: 84.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Every since injection my right arm injection location has been painful.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Pruritus, Urticaria
Clinical narrative: 70 y/o female, with h/o DM, HTN, CAD, states that she received a shingles vaccine yesterday. Six hours later, she developed diffuse hives as well as a very hot, red swollen left upper arm at the site of the injection. She denies chest pain, SOB, no difficulty breathing or other complaints. She has been taking 25 mg BENADRYL every 4 hours to help with the itchiness, but the hives are getting worse. And hives. Methylprednisolone 125 mg once, diphenhydramine 25 mg once.
Age: 65.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Rash, Rash erythematous
Clinical narrative: Redness rash, on (L) arm. Preferred of MD visit appt vs ER. Went to ER. Cancelled appt 12/19/18. N/S (no show appt) 12/20/18.
Age: 59.0
Sex: M
Vaccine: FLU4
Symptoms: Asthenia, Injection site pain
Clinical narrative: (L) thigh pain, decreased strength.
Age: 0.08
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Erythema, Irritability, Penile erythema, Penile swelling
Clinical narrative: Shots received at 9am approx, at 2pm child noted to be fussy, ate, noted red feet, soles and red bit swollen penis glans -  no other swelling, rash.
Age: 45.0
Sex: M
Vaccine: FLU4
Symptoms: Mobility decreased, Nuclear magnetic resonance imaging, X-ray
Clinical narrative: Right arm locked up for 6 weeks, could not raise above head for 7 months. X-ray and MRI. Shot was given to me out of surgery for ACDF neck.
Age: 60.0
Sex: M
Vaccine: FLUX
Symptoms: Eye pain, Eye swelling, Headache, Hypersensitivity, Ocular hyperaemia
Clinical narrative: Allergy like symptoms, runny nose, headache, sore, red, swollen eyes, sneezing.
Age: 60.0
Sex: M
Vaccine: FLUX
Symptoms: Rhinorrhoea, Sneezing
Clinical narrative: Allergy like symptoms, runny nose, headache, sore, red, swollen eyes, sneezing.
Age: 31.0
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Skin mass, Skin warm
Clinical narrative: This spontaneous case, initially received from other health professional on 20-Jun-2018, concerns a 31-year-old, adult female patient. The patient was allergic to purified protein derivative (PPD) solution. On an unspecified date in 2008, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date in 2008, after vaccination, the patient developed erythema on skin, ball under skin (mass) and was hot to touch. At the time of this report, the outcome of the events was not reported. The reporter assessed this case as non-serious. This case was cross-linked to the case: 201802526 (same patient). Update 27-Jul-2018: Non-significant case correction received with IRD 20-Jun-2018: The case comment was corrected. No changes were done in the narrative. Update received on 28-Aug-2018: Significant case correction performed with IRD 20-Jun-2018: As determined causality for all the events was changed from unassessable to related. Age at vaccination was added in the patient tab. Case comment updated accordingly. Update received on 20-Sep-2018: Significant case correction performed with IRD: 20-Jun-2018: As determined causality was changed from related to unassessable for all the 3 events due to lack of information regarding the onset latency. The narrative was amended.
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Cough, Feeling cold, Myalgia, Pyrexia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724399), concerns a female patient of unspecified age. On an unspecified date, the patient was administered influenza vaccine (dose, frequency, route of administration, anatomical location, batch number, trade name, manufacturer and expiry date: not reported). On an unspecified date, after vaccination, the patient had joint pain, fever, chills, muscle aches, coughing, sneezing and other respiratory issues. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUX
Symptoms: Respiratory disorder, Sneezing
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724399), concerns a female patient of unspecified age. On an unspecified date, the patient was administered influenza vaccine (dose, frequency, route of administration, anatomical location, batch number, trade name, manufacturer and expiry date: not reported). On an unspecified date, after vaccination, the patient had joint pain, fever, chills, muscle aches, coughing, sneezing and other respiratory issues. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUX
Symptoms: Cough, Dyspnoea, Ear pain, Headache, Lip pruritus
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724693), concerning an adult, female patient of an unspecified age. On an unspecified date in 2015, the patient was administered influenza vaccine, [dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported]. On an unspecified date in 2015, after vaccination, the patient experienced mobility decreased, cough, dyspnoea, ear pain, throat irritation, neck pain, pain in extremity, nausea, lip pruritus, pruritus and headache. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious. This case 201803630 was linked to 201803629 (same patient). Update received on 29-Sep-2018: Non-significant case correction (IRD: 26-Aug-2018): The sentence in the case comment was changed from 'as the case lacks information regarding the onset latency the causality of the events was unassessable' to 'as the case lacks information regarding the onset latency between the events and vaccination the causality of the events was unassessable'. No changes were made in the narrative.
Sex: F
Vaccine: FLUX
Symptoms: Mobility decreased, Nausea, Neck pain, Pain in extremity, Pruritus
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724693), concerning an adult, female patient of an unspecified age. On an unspecified date in 2015, the patient was administered influenza vaccine, [dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported]. On an unspecified date in 2015, after vaccination, the patient experienced mobility decreased, cough, dyspnoea, ear pain, throat irritation, neck pain, pain in extremity, nausea, lip pruritus, pruritus and headache. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious. This case 201803630 was linked to 201803629 (same patient). Update received on 29-Sep-2018: Non-significant case correction (IRD: 26-Aug-2018): The sentence in the case comment was changed from 'as the case lacks information regarding the onset latency the causality of the events was unassessable' to 'as the case lacks information regarding the onset latency between the events and vaccination the causality of the events was unassessable'. No changes were made in the narrative.
Sex: F
Vaccine: FLUX
Symptoms: Throat irritation
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724693), concerning an adult, female patient of an unspecified age. On an unspecified date in 2015, the patient was administered influenza vaccine, [dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported]. On an unspecified date in 2015, after vaccination, the patient experienced mobility decreased, cough, dyspnoea, ear pain, throat irritation, neck pain, pain in extremity, nausea, lip pruritus, pruritus and headache. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious. This case 201803630 was linked to 201803629 (same patient). Update received on 29-Sep-2018: Non-significant case correction (IRD: 26-Aug-2018): The sentence in the case comment was changed from 'as the case lacks information regarding the onset latency the causality of the events was unassessable' to 'as the case lacks information regarding the onset latency between the events and vaccination the causality of the events was unassessable'. No changes were made in the narrative.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Migraine
Clinical narrative: This non-serious spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724788), concerning a 52-year-old, adult, female patient. On an unspecified date, the patient was administered influenza vaccine, [dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported]. On an unspecified date, after vaccination, the patient experienced migraine. At the time of the report, the outcome of the event was not reported. This case was linked to 201803642 (same patient). Update received on (20-Sep-2018): Non-significant case correction received with IRD: 26-Aug-2018: The age at vaccination of the patient (52 years) was added in the patient tab.
Sex: F
Vaccine: FLUX
Symptoms: Cough, Myalgia, Respiratory tract congestion, Rhinorrhoea, Secretion discharge
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 725115), concerning a 57-year-old, adult, female patient. On an unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical site, trade name, manufacturer, batch number and expiry date: not reported). On an unspecified date after vaccination, the patient developed nagging persistent cough, a lot of mucous, runny nose, severe chest congestion and myalgia. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious. The case was cross-linked to the case 201803660 reported by the same reporter and patient.
Sex: F
Vaccine: FLUX
Symptoms: Loss of consciousness, Pyrexia
Clinical narrative: This serious spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 726271), concerns a female patient of unknown age. On an unspecified date, the patient was administered influenza vaccine (dose, route of administration, anatomical location, batch number, trade name, manufacturer and expiry date: not reported). On an unspecified date, after vaccination, the patient experienced high fever with loss of consciousness. At the time of this report, the outcome of the events was not reported. This case was cross-linked to case 201803562 due to the same patient. Update received on 19-Sep-2018: Non-significant case correction (IRD 26-Aug-2018): The state was updated in the vaccine administration section in the products tab.
Sex: F
Vaccine: FLUX
Symptoms: Back pain, Musculoskeletal pain
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 727032), concerns an adult female patient of unspecified age. The patient had a reaction to flu shot on an unspecified date in 2015. The patient experienced awful pain in her left upper back and shoulder area. On an unspecified date in 2016, the patient was administered (dose, frequency, route of administration, anatomical location, batch number, trade name, manufacturer and expiry date: not reported). On an unspecified date in 2016, after vaccination, the patient had a reaction to flu vaccine as awful pain in her left upper back and shoulder area. The outcome of the event was not reported. This case was linked to case: 201803671 and case: 201803669 due to same patient. Update received on 28-Sep-2018: Non-significant case correction (26-Aug-2018): The sentence in the narrative was corrected from 'on an unspecified date in 2016, after vaccination, the patient had reaction to flu vaccine' to 'on an unspecified date in 2016: after vaccination, the patient had a reaction to flu vaccine'.
Sex: M
Vaccine: FLUC4, FLUX
Symptoms: Cough, Headache, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 12-Sep-2018 by Seqirus from VAERS (VAERS ID: 734439), concerns a male patient of unspecified age. On an unspecified date, the patient was administered INN Flu Vaccine Seasonal [dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported]. On an unspecified date after vaccination, the patient experienced flu symptoms. At the time of this report, the outcome of the event was not reported. The reporter assessed this case as non-serious. This case 201803799 was cross-linked with case 201803798 due to same patient/reporter.
Sex: M
Vaccine: FLUC4, FLUX
Symptoms: Secretion discharge, Sneezing
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 12-Sep-2018 by Seqirus from VAERS (VAERS ID: 734439), concerns a male patient of unspecified age. On an unspecified date, the patient was administered INN Flu Vaccine Seasonal [dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported]. On an unspecified date after vaccination, the patient experienced flu symptoms. At the time of this report, the outcome of the event was not reported. The reporter assessed this case as non-serious. This case 201803799 was cross-linked with case 201803798 due to same patient/reporter.
Sex: M
Vaccine: FLUC4, FLUX
Symptoms: Influenza
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 12-Sep-2018 by Seqirus from VAERS (VAERS ID: 734439), concerns a male patient of unspecified age. On an unspecified date, the patient was administered INN Flu Vaccine Seasonal [dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported]. On an unspecified date after vaccination, the patient experienced flu symptoms. At the time of this report, the outcome of the event was not reported. The reporter assessed this case as non-serious. This case 201803799 was cross-linked with case 201803798 due to same patient/reporter.
Sex: F
Vaccine: FLUC4, FLUX
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 12-Sep-2018 by Seqirus from VAERS (VAERS ID 735277), concerns an adult female patient of an unspecified age. On an unspecified date (reported as for past 12 years), the patient was administered influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date, the patient experienced slight redness in a small area around the injection site. At the time of this report, the outcome of the event was not reported. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUC4, FLUX
Symptoms: Injection site erythema
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 12-Sep-2018 by Seqirus from VAERS (VAERS ID 735277), concerns an adult female patient of an unspecified age. On an unspecified date (reported as for past 12 years), the patient was administered influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date, the patient experienced slight redness in a small area around the injection site. At the time of this report, the outcome of the event was not reported. The reporter assessed the case as non-serious.
Age: 45.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Arthralgia, Dry skin, Skin discolouration
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 29-Jun-2018 by Seqirus from VAERS (VAERS ID: 736140), concerns a 45-year-old, adult male patient. The patient's medical history included an injury in his right inner hip due to bike accident, which bothered him prior to the flu shot. On an unspecified date, the patient was administered hepatitis A vaccine and experienced unspecified reaction. The patient's current illnesses included depression (reported as medical history), gluten sensitivity/allergy, gluten free diet and Gingko Biloba (stopped several days ago) due to allergy. The patient's concomitant medications included Duloxetine hydrochloride, Bupropion, Lorazepam, Vitamin K, pteropure pterostilbene, cell regenerator Nicotinamide riboside, Aspirin, Lutein Zeaxanthin, and professional grade Fish oil, all for unknown indications. On 24-Jan-2018, the patient received influenza vaccine [frequency reported as 1, route of administration: injection (reported as SYR), anatomical location: left arm, dose, batch number, expiry date and trade name: not reported]. On 30-Jan-2018, 7 days after vaccination, the patient developed small discoloration and rough spot within 2 inches of the injection site which appeared like a birth mark (more visible after a hot shower). The patient also had sensitivity in right hip and upper thigh nearby superficial layer of the skin which was painful on touch (almost like a cut). The patient noticed that after the patch on his arm and persisted as of 02-Mar-2018. At the time of this report, the patient was not recovered from the events (arthralgia, dry skin and skin discoloration). The reporter assessed this case as non-serious. Update received on 31-Jul-2018: Non-significant case correction (29-Jun-2019) - Added hepatitis A vaccine with unspecified adverse reaction in the vaccination history in narrative. Narrative was amended accordingly. Update received on 05-Sep-2018: Significant case correction (29-Jun-2018)- Added medical history suspected nonspecific reaction to hepatitis A vaccine in the other relevant history tab. The description as reported for the adverse events skin discoloration and skin rough was rephrased in the event tab. Added patient's age at vaccination in the patient tab.
Age: 45.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Arthralgia, Dry skin, Injection site discolouration, Injection site reaction, Pain in extremity
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 29-Jun-2018 by Seqirus from VAERS (VAERS ID: 736140), concerns a 45-year-old, adult male patient. The patient's medical history included an injury in his right inner hip due to bike accident, which bothered him prior to the flu shot. On an unspecified date, the patient was administered hepatitis A vaccine and experienced unspecified reaction. The patient's current illnesses included depression (reported as medical history), gluten sensitivity/allergy, gluten free diet and Gingko Biloba (stopped several days ago) due to allergy. The patient's concomitant medications included Duloxetine hydrochloride, Bupropion, Lorazepam, Vitamin K, pteropure pterostilbene, cell regenerator Nicotinamide riboside, Aspirin, Lutein Zeaxanthin, and professional grade Fish oil, all for unknown indications. On 24-Jan-2018, the patient received influenza vaccine [frequency reported as 1, route of administration: injection (reported as SYR), anatomical location: left arm, dose, batch number, expiry date and trade name: not reported]. On 30-Jan-2018, 7 days after vaccination, the patient developed small discoloration and rough spot within 2 inches of the injection site which appeared like a birth mark (more visible after a hot shower). The patient also had sensitivity in right hip and upper thigh nearby superficial layer of the skin which was painful on touch (almost like a cut). The patient noticed that after the patch on his arm and persisted as of 02-Mar-2018. At the time of this report, the patient was not recovered from the events (arthralgia, dry skin and skin discoloration). The reporter assessed this case as non-serious. Update received on 31-Jul-2018: Non-significant case correction (29-Jun-2019) - Added hepatitis A vaccine with unspecified adverse reaction in the vaccination history in narrative. Narrative was amended accordingly. Update received on 05-Sep-2018: Significant case correction (29-Jun-2018)- Added medical history suspected nonspecific reaction to hepatitis A vaccine in the other relevant history tab. The description as reported for the adverse events skin discoloration and skin rough was rephrased in the event tab. Added patient's age at vaccination in the patient tab.
Age: 45.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Pain of skin
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 29-Jun-2018 by Seqirus from VAERS (VAERS ID: 736140), concerns a 45-year-old, adult male patient. The patient's medical history included an injury in his right inner hip due to bike accident, which bothered him prior to the flu shot. On an unspecified date, the patient was administered hepatitis A vaccine and experienced unspecified reaction. The patient's current illnesses included depression (reported as medical history), gluten sensitivity/allergy, gluten free diet and Gingko Biloba (stopped several days ago) due to allergy. The patient's concomitant medications included Duloxetine hydrochloride, Bupropion, Lorazepam, Vitamin K, pteropure pterostilbene, cell regenerator Nicotinamide riboside, Aspirin, Lutein Zeaxanthin, and professional grade Fish oil, all for unknown indications. On 24-Jan-2018, the patient received influenza vaccine [frequency reported as 1, route of administration: injection (reported as SYR), anatomical location: left arm, dose, batch number, expiry date and trade name: not reported]. On 30-Jan-2018, 7 days after vaccination, the patient developed small discoloration and rough spot within 2 inches of the injection site which appeared like a birth mark (more visible after a hot shower). The patient also had sensitivity in right hip and upper thigh nearby superficial layer of the skin which was painful on touch (almost like a cut). The patient noticed that after the patch on his arm and persisted as of 02-Mar-2018. At the time of this report, the patient was not recovered from the events (arthralgia, dry skin and skin discoloration). The reporter assessed this case as non-serious. Update received on 31-Jul-2018: Non-significant case correction (29-Jun-2019) - Added hepatitis A vaccine with unspecified adverse reaction in the vaccination history in narrative. Narrative was amended accordingly. Update received on 05-Sep-2018: Significant case correction (29-Jun-2018)- Added medical history suspected nonspecific reaction to hepatitis A vaccine in the other relevant history tab. The description as reported for the adverse events skin discoloration and skin rough was rephrased in the event tab. Added patient's age at vaccination in the patient tab.
Sex: F
Vaccine: FLUC4, FLUX
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieve on 25-Sep-2018 by Seqirus from VAERS (VAERS ID: 736493), concerns an adult female patient. On an unspecified date in 2010, the patient was administered influenza vaccine [dose, route of administration, anatomical location, batch number, trade name and manufacturer: not reported]. On an unspecified date in 2010 after vaccination, the patient developed a red raised area of 2.5 x 1.5 cm, which was painful and very warm to touch. On an unspecified date, the patient was treated with unspecified steroids by the physician. At the time of this report, the outcome of the events was unknown. The reporter considered the events as related to the suspect vaccine. This case 201803962 was linked to case number 201803961 due to the same patient. Update received on 30-Oct-2018: Non-significant case correction (IRD: 25-Sep-2018): Added treatment details (unspecified steroid) for the events in the narrative.
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Asthenia, Blood glucose increased, Malaise
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 02-Aug-2018 by Seqirus from VAERS (VAERS ID: 743286), concerning a 62-year-old, adult, male patient. On an unspecified date in 2010, the patient received his first flu shot and since then he got sick with every flu shot. On unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number and expiry date, manufacturer and trade name: not reported). On an unspecified date after vaccination, the patient experienced weakness (described as beaten down) and increase in blood glucose level. The outcome of the events was unknown. The reporter assessed the events as non-serious. This case was cross-linked to the case: 201803100 (same patient). Update received on 20-Sep-2018: Significant case correction (IRD 02-Aug-2018): As determined causality for the event 'malaise' was changed from related to unassessable in the event assessment tab. The rationale in the case comment was changed to 'The company assessed the causality of the events as unassessable due to lack of onset latency period'.
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Asthenia, Blood glucose increased, Feeling abnormal
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 02-Aug-2018 by Seqirus from VAERS (VAERS ID: 743286), concerning a 62-year-old, adult, male patient. On an unspecified date in 2010, the patient received his first flu shot and since then he got sick with every flu shot. On unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number and expiry date, manufacturer and trade name: not reported). On an unspecified date after vaccination, the patient experienced weakness (described as beaten down) and increase in blood glucose level. The outcome of the events was unknown. The reporter assessed the events as non-serious. This case was cross-linked to the case: 201803100 (same patient). Update received on 20-Sep-2018: Significant case correction (IRD 02-Aug-2018): As determined causality for the event 'malaise' was changed from related to unassessable in the event assessment tab. The rationale in the case comment was changed to 'The company assessed the causality of the events as unassessable due to lack of onset latency period'.
Age: 65.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Injected limb mobility decreased, Injection site pain, Pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Aug-2018 by Seqirus from VAERS (VAERS ID: 743756), concerns a 65-year-old, elderly female patient. The patient had no historical condition. The patient was allergic to CIPRO (caused severe vomiting). The patient's concomitant medications included pantoprazole, tramadol, meloxicam, pramipexole, ZIAC and quetiapine for unknown indications. On 27-Sep-2017, the patient was administered FLUAD (TIV) [dose: 0.5 ml, frequency reported as unknown, route of administration: injection (reported at SYR), anatomical location: left arm, batch number and expiry date: not reported). The patient experienced pain at the time of injection. On 29-Sep-2017, 2 days after vaccination, the patient experienced severe pain in the left upper arm. The patient could not lay on the left side. The patient could lift left arm above 90 degrees without sharp pain and the pain was the same as the time of injection. The patient did not receive any treatment for the events. At the time of this report, the patient had not recovered from the events. The reporter assessed this case as non-serious. Update 29-Aug-2018: Significant case correction was performed with IRD 06-Aug-2018: The verbatim for the event 'injection site pain' was changed from 'pain is the same as the time of injection' to 'severe pain in left upper arm'. The event 'pain in extremity' was changed to 'pain (verbatim: pain is the same as the time of injection)' and listedness was changed accordingly. Case comment and narrative was amended.
Age: 65.0
Sex: F
Vaccine: FLUA3, FLUA3
Symptoms: Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Aug-2018 by Seqirus from VAERS (VAERS ID: 743756), concerns a 65-year-old, elderly female patient. The patient had no historical condition. The patient was allergic to CIPRO (caused severe vomiting). The patient's concomitant medications included pantoprazole, tramadol, meloxicam, pramipexole, ZIAC and quetiapine for unknown indications. On 27-Sep-2017, the patient was administered FLUAD (TIV) [dose: 0.5 ml, frequency reported as unknown, route of administration: injection (reported at SYR), anatomical location: left arm, batch number and expiry date: not reported). The patient experienced pain at the time of injection. On 29-Sep-2017, 2 days after vaccination, the patient experienced severe pain in the left upper arm. The patient could not lay on the left side. The patient could lift left arm above 90 degrees without sharp pain and the pain was the same as the time of injection. The patient did not receive any treatment for the events. At the time of this report, the patient had not recovered from the events. The reporter assessed this case as non-serious. Update 29-Aug-2018: Significant case correction was performed with IRD 06-Aug-2018: The verbatim for the event 'injection site pain' was changed from 'pain is the same as the time of injection' to 'severe pain in left upper arm'. The event 'pain in extremity' was changed to 'pain (verbatim: pain is the same as the time of injection)' and listedness was changed accordingly. Case comment and narrative was amended.
Sex: M
Vaccine: FLUC4, FLUX
Symptoms: Arthralgia, Chills, Decreased immune responsiveness, Headache, Impaired work ability
Clinical narrative: This non-serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Sep-2018 by Seqirus from VAERS (VAERS ID: 744857), concerns a male patient of an unspecified age. On an unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date after vaccination, the patient experienced fever, chills, malaise, arthralgia and myalgia for 5-7 days duration. The patient also experienced headache, nausea and rhinorrhoea. The patient missed several days of work due to these events. At the time of this report, the outcome of the events was not reported. This case 201803965 was cross-linked with the original case 201803964 due to the same patient and reporter.
Sex: M
Vaccine: FLUC4, FLUX
Symptoms: Malaise, Myalgia, Nausea, Pyrexia, Rhinorrhoea
Clinical narrative: This non-serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Sep-2018 by Seqirus from VAERS (VAERS ID: 744857), concerns a male patient of an unspecified age. On an unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date after vaccination, the patient experienced fever, chills, malaise, arthralgia and myalgia for 5-7 days duration. The patient also experienced headache, nausea and rhinorrhoea. The patient missed several days of work due to these events. At the time of this report, the outcome of the events was not reported. This case 201803965 was cross-linked with the original case 201803964 due to the same patient and reporter.
Sex: M
Vaccine: FLUC4, FLUX
Symptoms: Arthralgia, Chills, Headache, Impaired work ability, Malaise
Clinical narrative: This non-serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Sep-2018 by Seqirus from VAERS (VAERS ID: 744857), concerns a male patient of an unspecified age. On an unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date after vaccination, the patient experienced fever, chills, malaise, arthralgia and myalgia for 5-7 days duration. The patient also experienced headache, nausea and rhinorrhoea. The patient missed several days of work due to these events. At the time of this report, the outcome of the events was not reported. This case 201803965 was cross-linked with the original case 201803964 due to the same patient and reporter.
Sex: M
Vaccine: FLUC4, FLUX
Symptoms: Myalgia, Nausea, Pyrexia, Rhinorrhoea
Clinical narrative: This non-serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Sep-2018 by Seqirus from VAERS (VAERS ID: 744857), concerns a male patient of an unspecified age. On an unspecified date, the patient was administered influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date after vaccination, the patient experienced fever, chills, malaise, arthralgia and myalgia for 5-7 days duration. The patient also experienced headache, nausea and rhinorrhoea. The patient missed several days of work due to these events. At the time of this report, the outcome of the events was not reported. This case 201803965 was cross-linked with the original case 201803964 due to the same patient and reporter.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Cough, Lower respiratory tract congestion, Pain, Pulmonary physical examination, Pyrexia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 02-Aug-2018 by Seqirus from VAERS (VAERS ID: 744961), concerning an adult, female patient of an unspecified age. On unspecified date in 2009, the patient administered the influenza vaccine and 2 weeks after vaccination, developed reproducible likely non-immunoglobulin E [IgE] mediated reactions which included fever with a temperature 101-104, body aches, upper and lower respiratory tract congestion and cough which persisted for several weeks. The patient's current condition included allergic rhinitis (reported as medical history) and was allergic to sulfa drugs. On an unspecified date in 2010, the patient was administered Influenza vaccine, dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date in 2010, two weeks after vaccination, the patient experienced reproducible likely non-IgE mediated reactions (reproducible with subsequent vaccinations of approximately same severity) like fever (101-104-degree), body aches, upper and lower respiratory tract congestion and cough persisting for several weeks. The patient did not decline yearly vaccinations as she worked as a registered nurse in a hospital. At the time of this report, the outcome of the events was not reported. The reporter assessed this case as non-serious. This case was linked to the case (201803106) reported by the same reporter. Update 29-Aug-2018: Significant case correction was performed with IRD 02-Aug-2018: Current conditions -allergic rhinitis and sulfa drug allergy were added in patient tab. The narrative was amended accordingly.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Upper respiratory tract congestion
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 02-Aug-2018 by Seqirus from VAERS (VAERS ID: 744961), concerning an adult, female patient of an unspecified age. On unspecified date in 2009, the patient administered the influenza vaccine and 2 weeks after vaccination, developed reproducible likely non-immunoglobulin E [IgE] mediated reactions which included fever with a temperature 101-104, body aches, upper and lower respiratory tract congestion and cough which persisted for several weeks. The patient's current condition included allergic rhinitis (reported as medical history) and was allergic to sulfa drugs. On an unspecified date in 2010, the patient was administered Influenza vaccine, dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date in 2010, two weeks after vaccination, the patient experienced reproducible likely non-IgE mediated reactions (reproducible with subsequent vaccinations of approximately same severity) like fever (101-104-degree), body aches, upper and lower respiratory tract congestion and cough persisting for several weeks. The patient did not decline yearly vaccinations as she worked as a registered nurse in a hospital. At the time of this report, the outcome of the events was not reported. The reporter assessed this case as non-serious. This case was linked to the case (201803106) reported by the same reporter. Update 29-Aug-2018: Significant case correction was performed with IRD 02-Aug-2018: Current conditions -allergic rhinitis and sulfa drug allergy were added in patient tab. The narrative was amended accordingly.